Christoph Bausch

Insider Reports History

Location
Sioux Falls, SD
Signature
/s/ Christoph Bausch
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christoph Bausch:

Company Role Class Num Shares Value Price $ Report Date Ownership
SAB Biotherapeutics, Inc. CHIEF OPERATING OFFICER Stock option (right to buy) 1,800,000 03 Feb 2026 Direct

Insider Reports Filed by Christoph Bausch

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SABS SAB Biotherapeutics, Inc. 03 Feb 2026 1 $0 4 CHIEF OPERATING OFFICER 05 Feb 2026, 16:45
SABS SAB Biotherapeutics, Inc. 26 Aug 2025 1 $0 4 CHIEF OPERATING OFFICER 28 Aug 2025, 17:00
SABS SAB Biotherapeutics, Inc. 21 Feb 2024 1 $0 4 CHIEF OPERATING OFFICER 23 Feb 2024, 16:50
SABS SAB Biotherapeutics, Inc. 14 Mar 2023 1 $0 4 Chief Operating Officer 16 Mar 2023, 16:28
SABS SAB Biotherapeutics, Inc. 13 Sep 2022 1 $0 4 CHIEF OPERATING OFFICER 15 Sep 2022, 16:45
SABS SAB Biotherapeutics, Inc. 16 Mar 2022 1 $0 4 Chief Science Officer 18 Mar 2022, 21:15
SABS SAB Biotherapeutics, Inc. 22 Oct 2021 3 $0 4/A Chief Science Officer 24 Nov 2021, 18:37
SABS Big Cypress Acquisition Corp. 22 Oct 2021 0 $0 3 Chief Science Officer 22 Oct 2021, 21:26